GO:0015024 glucuronate-2-sulfatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015024 (glucuronate-2-sulfatase activity) is a molecular_function term describing the hydrolysis of 2-sulfate groups from 2-O-sulfo-D-glucuronate residues in chondroitin sulfate, heparin and heparitin sulfate [QuickGO definition].
• The activity was first characterized biochemically in human skin fibroblasts and liver, where it removes sulfate from glucuronic acid residues of glycosaminoglycans [1,4].
• Arylsulfatase K (ARSK) is the lysosomal enzyme responsible for this 2-sulfoglucuronate sulfatase activity, and its loss causes a mucopolysaccharidosis-like phenotype [2,6].
• Deficiency of glucuronate-2-sulfatase activity leads to accumulation of heparan and chondroitin sulfate-derived oligosaccharides, linking the term to lysosomal storage disorders.
• The enzyme acts on sulfated glycosaminoglycan substrates, and specific iduronate-2-sulfate glycosides have been developed as substrates for related sulfatase assays.
• Research on GO:0015024 relies on biochemical assays, knockout cell models and glycosaminoglycan profiling to dissect its role in lysosomal catabolism [1,2,6].
Description
GO:0015024, glucuronate-2-sulfatase activity, is a molecular_function term in the Gene Ontology that describes the catalysis of 2-sulfate group hydrolysis from 2-O-sulfo-D-glucuronate residues within chondroitin sulfate, heparin and heparitin sulfate [QuickGO definition]. This activity is part of the lysosomal degradation pathway for glycosaminoglycans, where sequential removal of sulfate and sugar residues is required for complete breakdown of these complex polysaccharides [1,4]. The term is distinct from iduronate-2-sulfatase activity, which acts on iduronic acid residues, and its precise definition is critical for annotating enzymes involved in glycosaminoglycan catabolism [2,5]. Biochemical studies in the early 1990s purified and characterized glucuronate-2-sulfatase from human liver and cultured skin fibroblasts, establishing its substrate specificity and catalytic properties [1,4]. More recent work identified arylsulfatase K (ARSK) as the lysosomal enzyme responsible for this activity, and its inactivation in mice and humans leads to a mucopolysaccharidosis-like disorder characterized by accumulation of heparan and chondroitin sulfate [2,6]. This connection has made GO:0015024 a focal point for understanding lysosomal storage diseases and for developing diagnostic and therapeutic strategies. For researchers, GO:0015024 provides a precise functional annotation to distinguish this sulfatase from other glycosaminoglycan-degrading enzymes. It is used in gene ontology enrichment analyses, enzyme annotation pipelines and studies of lysosomal biology [1,2,6]. Understanding its mechanism, regulation and disease relevance is essential for modeling mucopolysaccharidoses and for designing targeted therapies.
glucuronate-2-sulfatase activity At A Glance
| GO ID | GO:0015024 |
|---|---|
| GO term | glucuronate-2-sulfatase activity |
| Ontology | molecular_function |
| Synonym | chondro-2-sulfatase activity; glucuronate-2-sulphatase activity; glucurono-2-sulfatase activity; polysaccharide-2-O-sulfo-D-glucuronate 2-sulfohydrolase activity |
| Major function | Hydrolysis of 2-sulfate groups from 2-O-sulfo-D-glucuronate residues in chondroitin sulfate, heparin and heparitin sulfate |
| Substrate | 2-O-sulfo-D-glucuronate residues within glycosaminoglycans |
| Cellular location | Lysosome (as inferred from enzyme characterization and disease phenotypes) |
| Associated enzyme | Arylsulfatase K (ARSK) is the lysosomal 2-sulfoglucuronate sulfatase [2,6] |
| Related disease | Mucopolysaccharidosis-like disorder due to deficient glucuronate desulfation |
What Is GO:0015024?
Glucuronate-2-sulfatase activity (GO:0015024) is the enzymatic hydrolysis of the 2-sulfate ester bond on 2-O-sulfo-D-glucuronate residues found in chondroitin sulfate, heparin and heparitin sulfate. In other words, it is a sulfatase that removes sulfate from glucuronic acid units within these glycosaminoglycans, a step required for their complete lysosomal degradation [QuickGO definition; 1,4].
Why Is glucuronate-2-sulfatase activity Important in Cell Biology?
GO:0015024 is important because it defines a critical step in glycosaminoglycan catabolism, and its deficiency causes a lysosomal storage disorder with accumulation of heparan and chondroitin sulfate. The activity is also essential for accurate annotation of sulfatase enzymes in genomic and proteomic studies, and it provides a functional marker to distinguish arylsulfatase K from other sulfatases [2,6]. Understanding this activity helps researchers model mucopolysaccharidoses, develop diagnostic substrates and evaluate therapeutic strategies targeting lysosomal degradation [1,2,5,6].
• Deficiency of glucuronate-2-sulfatase activity causes a mucopolysaccharidosis-like phenotype with heparan and chondroitin sulfate accumulation.
• The activity is required for complete lysosomal degradation of chondroitin sulfate, heparin and heparitin sulfate [1,4].
• Arylsulfatase K (ARSK) is the enzyme responsible for this activity, linking the GO term to a specific gene product [2,6].
• Biochemical assays for glucuronate-2-sulfatase activity are used to diagnose and study sulfatase deficiencies [1,4].
• Specific iduronate-2-sulfate glycosides have been developed as substrates for related sulfatase assays, aiding in differential diagnosis.
• The term is used in GO enrichment analyses to annotate genes involved in glycosaminoglycan metabolism and lysosomal function [1,2,6].
• Knockout models of ARSK provide insights into the pathobiology of glucuronate desulfation defects.
• Understanding this activity supports the development of enzyme replacement or small-molecule therapies for lysosomal storage diseases.
• The activity is distinct from iduronate-2-sulfatase, and correct annotation prevents misclassification of sulfatase functions [2,5].
• Research on GO:0015024 informs studies of extracellular matrix remodeling and cell signaling involving sulfated glycosaminoglycans [1,4].
Molecular Mechanism of glucuronate-2-sulfatase activity
Substrate Recognition and Binding
In simple terms: The enzyme finds and grabs onto specific sulfated sugar chains.
Glucuronate-2-sulfatase recognizes 2-O-sulfo-D-glucuronate residues within chondroitin sulfate, heparin and heparitin sulfate [QuickGO definition]. Biochemical studies using human liver and fibroblast homogenates demonstrated that the enzyme specifically acts on glucuronic acid residues bearing a 2-sulfate group, distinguishing it from sulfatases that target iduronic acid [1,4]. The substrate specificity was confirmed by assays with defined glycosaminoglycan fragments.
Catalytic Hydrolysis of the 2-Sulfate Group
In simple terms: The enzyme cuts off the sulfate group from the sugar.
The catalytic mechanism involves hydrolysis of the 2-sulfate ester bond, releasing sulfate and leaving a desulfated glucuronic acid residue [QuickGO definition]. Purified human liver glucuronate-2-sulphatase was shown to catalyze this reaction with optimal activity at acidic pH, consistent with a lysosomal location. The reaction is essential for the sequential degradation of glycosaminoglycans, as the remaining sulfate would block further exoglycosidase action [1,4].
Enzyme Identity: Arylsulfatase K
In simple terms: A specific protein called arylsulfatase K does this job in the lysosome.
Arylsulfatase K (ARSK) was identified as the lysosomal 2-sulfoglucuronate sulfatase responsible for GO:0015024 activity. Inactivation of ARSK in mice and humans leads to deficient glucuronate desulfation of heparan and chondroitin sulfate, confirming its role in vivo. This discovery linked the biochemical activity to a specific gene and provided a molecular basis for a mucopolysaccharidosis-like disease [2,6].
Role in Glycosaminoglycan Catabolism
In simple terms: This enzyme is one of many that break down long sugar chains in the lysosome.
Glucuronate-2-sulfatase acts in concert with other lysosomal enzymes to fully degrade chondroitin sulfate, heparin and heparitin sulfate [1,4]. Its action removes sulfate groups that would otherwise inhibit further degradation, and deficiency leads to accumulation of partially degraded oligosaccharides. This step is therefore critical for maintaining lysosomal homeostasis and preventing storage material buildup.
Assay and Substrate Specificity
In simple terms: Scientists use specific substrates to measure this enzyme's activity.
The activity has been measured in cultured human skin fibroblast homogenates and purified from human liver using radiolabeled or fluorogenic substrates [1,4]. A sulfatase specific for glucuronic acid 2-sulfate residues in glycosaminoglycans was characterized, providing a basis for specific assays. More recently, iduronate-2-sulfate glycosides have been synthesized as substrates for related sulfatases, aiding in differential diagnosis of mucopolysaccharidoses.
Key Genes Involved in GO:0015024 glucuronate-2-sulfatase activity
The following genes and proteins are directly or functionally linked to glucuronate-2-sulfatase activity (GO:0015024) based on published biochemical and genetic studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ARSK | Encodes arylsulfatase K, the lysosomal 2-sulfoglucuronate sulfatase responsible for GO:0015024 activity [2,6] | Knockout models show mucopolysaccharidosis-like phenotype; key for studying disease mechanism |
| IDS | Encodes iduronate-2-sulfatase, which removes sulfate from iduronic acid residues, a related but distinct activity | Used to differentiate substrate specificity from glucuronate-2-sulfatase; relevant for MPS II diagnosis |
| GUSB | Encodes beta-glucuronidase, which removes glucuronic acid residues after desulfation [1,4] | Downstream enzyme in glycosaminoglycan degradation; its activity depends on prior desulfation [1,4] |
| SULF1 | Encodes sulfatase 1, which acts on heparan sulfate but with different substrate specificity | Helps distinguish related sulfatases in annotation and functional studies |
| SULF2 | Encodes sulfatase 2, another heparan sulfate-modifying enzyme | Comparative studies of sulfatase specificity |
| HGSNAT | Encodes heparan-alpha-glucosaminide N-acetyltransferase, involved in heparan sulfate degradation | Part of the same lysosomal pathway; mutations cause MPS IIIC |
| NAGLU | Encodes alpha-N-acetylglucosaminidase, another heparan sulfate degrading enzyme | Defects cause MPS IIIB; relevant for pathway context |
| SGSH | Encodes N-sulfoglucosamine sulfohydrolase, which removes sulfate from glucosamine residues | Defects cause MPS IIIA; part of the same catabolic cascade |
| IDUA | Encodes alpha-L-iduronidase, which cleaves iduronic acid residues | Defects cause MPS I; related to glycosaminoglycan degradation |
| GALNS | Encodes N-acetylgalactosamine-6-sulfatase, which acts on chondroitin sulfate | Defects cause MPS IVA; relevant for chondroitin sulfate catabolism |
| ARSB | Encodes arylsulfatase B, which removes sulfate from N-acetylgalactosamine-4-sulfate | Defects cause MPS VI; another sulfatase in the pathway |
| GNS | Encodes glucosamine-6-sulfatase, which acts on heparan sulfate | Defects cause MPS IIID; part of the same degradation pathway |
| HYAL1 | Encodes hyaluronidase 1, which degrades hyaluronic acid | Related glycosaminoglycan degradation enzyme |
| CTSA | Encodes cathepsin A, which stabilizes several lysosomal enzymes including sulfatases | Protective protein for sulfatases; relevant for enzyme stability |
| PSAP | Encodes prosaposin, a precursor for saposins that activate glycosphingolipid degradation | Not directly linked but part of lysosomal degradation context |
| NPC1 | Encodes NPC1, involved in lysosomal cholesterol transport | Not directly linked but lysosomal function context |
| LAMP1 | Encodes lysosomal-associated membrane protein 1, a marker of lysosomes | Used as a lysosomal marker in studies of storage disorders |
| TFEB | Encodes transcription factor EB, a master regulator of lysosomal biogenesis | Regulates expression of lysosomal enzymes including sulfatases |
How Is glucuronate-2-sulfatase activity Regulated?
The expression and activity of glucuronate-2-sulfatase are regulated as part of the lysosomal biogenesis program. Transcription factor EB (TFEB) controls the expression of many lysosomal genes, and its activity can influence the levels of enzymes involved in glycosaminoglycan degradation. Additionally, the enzyme requires an acidic pH for optimal activity, consistent with lysosomal localization. Post-translational modification and proteolytic processing may also regulate sulfatase activity, as seen for other lysosomal sulfatases [2,6]. However, specific regulatory mechanisms for ARSK remain an active area of research.
glucuronate-2-sulfatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ARSK | Mucopolysaccharidosis-like disorder due to deficient glucuronate desulfation | Arsk knockout mouse; patient-derived fibroblasts |
| IDS | Mucopolysaccharidosis II (Hunter syndrome) due to iduronate-2-sulfatase deficiency | IDS knockout cell lines; enzyme activity assays |
| GUSB | Mucopolysaccharidosis VII (Sly syndrome) due to beta-glucuronidase deficiency [1,4] | Gusb mutant mice; fibroblast assays [1,4] |
| SULF1/SULF2 | Altered heparan sulfate sulfation in cancer and developmental disorders | Knockout and overexpression cell models |
| HGSNAT | Mucopolysaccharidosis IIIC due to heparan-alpha-glucosaminide N-acetyltransferase deficiency | Hgsnat knockout mice; enzyme assays |
Mucopolysaccharidosis-like Disorder Due to ARSK Deficiency
Inactivation of arylsulfatase K (ARSK), the enzyme responsible for glucuronate-2-sulfatase activity, causes a mucopolysaccharidosis-like disorder characterized by deficient glucuronate desulfation of heparan and chondroitin sulfate. Affected individuals and mouse models accumulate partially degraded glycosaminoglycans, leading to lysosomal storage and multi-systemic pathology. This condition is distinct from other mucopolysaccharidoses but shares clinical features such as skeletal abnormalities and organomegaly.
Diagnostic Relevance for Mucopolysaccharidoses
Assays for glucuronate-2-sulfatase activity are used in the differential diagnosis of mucopolysaccharidoses, particularly to distinguish defects in glucuronate desulfation from iduronate-2-sulfatase deficiency (MPS II) [1,5]. Specific substrates such as iduronate-2-sulfate glycosides have been developed to measure related sulfatase activities, aiding in accurate diagnosis. Biochemical characterization of the enzyme in fibroblasts and liver provides reference data for clinical testing [1,4].
Role in Lysosomal Storage and Neurodegeneration
Deficiency of glucuronate-2-sulfatase activity leads to accumulation of heparan sulfate, which is associated with neuropathology in several mucopolysaccharidoses. Although direct neurodegeneration has not been extensively documented for ARSK deficiency, the accumulation of heparan and chondroitin sulfate oligosaccharides can impact lysosomal function and cellular homeostasis. Further research is needed to fully define the neurological consequences.
From glucuronate-2-sulfatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ARSK cause accumulation of specific glycosaminoglycans? | ARSK knockout cell line (e.g., HEK293 or fibroblasts) |
| What is the substrate specificity of glucuronate-2-sulfatase? | Purified enzyme or cell lysates from ARSK-overexpressing cells [1,4] |
| Can a point mutation in ARSK abolish catalytic activity? | Point-mutation knock-in cell model [2,6] |
| Does tagging ARSK with a fluorescent protein affect its lysosomal localization? | Knock-in of tagged ARSK |
| Does overexpression of ARSK enhance glycosaminoglycan degradation? | ARSK overexpression cell line |
| Which genes are co-regulated with ARSK in lysosomal storage? | CRISPR library screening and transcriptomics |
How to Study the glucuronate-2-sulfatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Hydrolysis of 2-sulfate from glucuronate residues | Diagnosis of sulfatase deficiencies; kinetic studies [1,4] |
| LC-MS glycosaminoglycan profiling | Accumulation of heparan and chondroitin sulfate oligosaccharides | Validation of ARSK knockout phenotypes |
| CRISPR-Cas9 knockout | Loss of ARSK function | Modeling mucopolysaccharidosis-like disorder |
| Site-directed mutagenesis | Effect of point mutations on catalytic activity | Identifying essential residues [2,6] |
| Fluorescent tagging | Subcellular localization of ARSK | Confirming lysosomal targeting |
| RNA-seq | Transcriptional changes in lysosomal genes | Identifying co-regulated pathways |
| Proteomics | Protein abundance and interactions | Discovering ARSK binding partners |
| Immunofluorescence | Cellular distribution of glycosaminoglycans | Visualizing storage material |
Biochemical Enzyme Assays
Glucuronate-2-sulfatase activity is typically measured using radiolabeled or fluorogenic substrates derived from glycosaminoglycans. The original assays used cultured human skin fibroblast homogenates and purified liver enzyme to detect release of sulfate from 2-O-sulfo-D-glucuronate residues [1,4]. A specific sulfatase for glucuronic acid 2-sulfate residues was characterized using such substrates. These assays remain the gold standard for measuring enzyme activity in cells and tissues [1,4].
Glycosaminoglycan Profiling
To assess the functional consequences of altered glucuronate-2-sulfatase activity, researchers profile glycosaminoglycan species using liquid chromatography-mass spectrometry (LC-MS) or gel electrophoresis. In ARSK-deficient models, accumulation of heparan and chondroitin sulfate-derived oligosaccharides is observed. This method provides direct evidence of substrate accumulation and is used to validate knockout phenotypes.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 is used to generate knockout, point-mutation and knock-in models of ARSK and related genes. Knockout cell lines confirm the role of ARSK in glucuronate desulfation and mimic the disease phenotype. Point mutations can be introduced to test catalytic residues, while tagged knock-ins allow visualization of enzyme localization [2,6]. These models are essential for dissecting the molecular mechanism of GO:0015024.
Transcriptomics and Proteomics
RNA sequencing and proteomics can reveal changes in lysosomal gene expression and enzyme abundance upon ARSK manipulation. TFEB-regulated genes, including other sulfatases, may be coordinately regulated. Proteomic analysis of lysosomal fractions can identify interaction partners and post-translational modifications of ARSK. These approaches help place GO:0015024 in the broader context of lysosomal biology.
How CRISPR Can Be Used to Study GO:0015024 glucuronate-2-sulfatase activity
Knockout
CRISPR-Cas9 knockout of ARSK in cell lines such as HEK293 or patient fibroblasts abolishes glucuronate-2-sulfatase activity, leading to accumulation of heparan and chondroitin sulfate. These models recapitulate key features of the mucopolysaccharidosis-like disorder and are used to study disease mechanisms and test therapeutic interventions. Knockout of related sulfatases (e.g., IDS) helps differentiate substrate specificities.
Point Mutation
Point mutations can be introduced into the ARSK gene to test the role of specific amino acids in catalysis or substrate binding. For example, mutation of the catalytic cysteine residue conserved in sulfatases would be expected to abolish activity [2,6]. Such models provide precise structure-function insights and can mimic patient mutations.
Knock-in
Knock-in of a tagged ARSK (e.g., GFP or HA) allows real-time tracking of enzyme localization and trafficking to the lysosome. Knock-in of disease-associated mutations can create isogenic models to study genotype-phenotype relationships. These models are valuable for high-content imaging and biochemical assays.
Overexpression
Overexpression of ARSK in cell lines can enhance glycosaminoglycan degradation and reduce storage material, providing a gain-of-function model. Overexpression is also used to produce recombinant enzyme for biochemical characterization and substrate specificity studies [1,4]. This approach helps confirm that ARSK is sufficient for glucuronate-2-sulfatase activity.
How EDITGENE Supports glucuronate-2-sulfatase activity Research
Researchers studying glucuronate-2-sulfatase activity-related genes often need to determine whether a candidate gene is causally involved in glycosaminoglycan catabolism, lysosomal storage or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes like ARSK and its partners.
Contact EDITGENE today to design your custom CRISPR model for glucuronate-2-sulfatase activity research.
Frequently Asked Questions About glucuronate-2-sulfatase activity
What is glucuronate-2-sulfatase activity?
Glucuronate-2-sulfatase activity (GO:0015024) is the enzymatic hydrolysis of 2-sulfate groups from 2-O-sulfo-D-glucuronate residues in chondroitin sulfate, heparin and heparitin sulfate [QuickGO definition; 1,4].
What gene encodes glucuronate-2-sulfatase activity?
Arylsulfatase K (ARSK) encodes the lysosomal enzyme responsible for this activity [2,6].
What diseases are associated with glucuronate-2-sulfatase deficiency?
Deficiency causes a mucopolysaccharidosis-like disorder with accumulation of heparan and chondroitin sulfate.
How is glucuronate-2-sulfatase activity measured?
It is measured using radiolabeled or fluorogenic substrates in cell homogenates or purified enzyme preparations [1,4].
What is the difference between glucuronate-2-sulfatase and iduronate-2-sulfatase?
Glucuronate-2-sulfatase acts on glucuronic acid residues, while iduronate-2-sulfatase acts on iduronic acid residues; they are distinct enzymes with different substrate specificities [2,5].
What are the synonyms for GO:0015024?
Synonyms include chondro-2-sulfatase activity, glucuronate-2-sulphatase activity, glucurono-2-sulfatase activity and polysaccharide-2-O-sulfo-D-glucuronate 2-sulfohydrolase activity [QuickGO].
Which glycosaminoglycans are substrates for glucuronate-2-sulfatase?
Chondroitin sulfate, heparin and heparitin sulfate contain the 2-O-sulfo-D-glucuronate residues targeted by this enzyme [QuickGO definition].
Is glucuronate-2-sulfatase activity localized to lysosomes?
Yes, the enzyme is lysosomal, as indicated by its acidic pH optimum and the lysosomal storage phenotype upon deficiency [4,6].
Can CRISPR be used to study glucuronate-2-sulfatase activity?
Yes, CRISPR-Cas9 knockout, point mutation and knock-in models of ARSK are used to study its function and disease relevance.
What model systems exist for glucuronate-2-sulfatase research?
ARSK knockout mice and patient-derived fibroblasts are established models; cell lines with CRISPR edits are also widely used.
Conclusion
GO:0015024 glucuronate-2-sulfatase activity defines a specific lysosomal sulfatase step essential for glycosaminoglycan degradation. The identification of ARSK as the responsible enzyme has linked this activity to a mucopolysaccharidosis-like disorder, providing a clear disease context [2,6]. Biochemical assays and CRISPR models continue to advance our understanding of its mechanism and regulation [1,4,6]. For researchers, precise annotation of GO:0015024 is critical for distinguishing it from related sulfatases and for interpreting genomic data in lysosomal biology. EDITGENE's CRISPR services enable the creation of tailored cell models to dissect this activity and its role in human disease.
References
- 1. Freeman C et al.. 1991. Glucuronate-2-sulphatase activity in cultured human skin fibroblast homogenates.. Biochem J 279 ( Pt 2)(Pt 2):399-405 PMID: 1953637
- 2. Dhamale OP et al.. 2017. Arylsulfatase K is the Lysosomal 2-Sulfoglucuronate Sulfatase.. ACS Chem Biol 12(2):367-373 PMID: 28055182
- 3. Shaklee PN et al.. 1985. A sulfatase specific for glucuronic acid 2-sulfate residues in glycosaminoglycans.. J Biol Chem 260(16):9146-9 PMID: 4019466
- 4. Freeman C et al.. 1989. Human liver glucuronate 2-sulphatase. Purification, characterization and catalytic properties.. Biochem J 259(1):209-16 PMID: 2497731
- 5. Singh G et al.. 2025. A new route for the preparation of iduronate-2-sulfate glycosides: A new substrate for iduronate-2-sulfatase for screening and diagnosis of Mucopolysaccharidosis-II.. Carbohydr Res 555:109585 PMID: 40592241
- 6. Trabszo C et al.. 2020. Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.. Biochem J 477(17):3433-3451 PMID: 32856704
